US Broker Ratings

Sprout Social, Inc (SPT) Stock Analysis: Uncovering a 42% Potential Upside

Sprout Social, Inc. (NYSE: SPT), a key player in the ever-evolving technology sector, is catching the attention of investors with its robust social media management platform. With a market cap..

Abeona Therapeutics Inc. (ABEO) Investor Outlook: Eyeing a 315% Potential Upside in the Biotech Space

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical player, is attracting attention with its remarkable potential upside of 315.35%, as indicated by analyst target prices. Specializing in gene and cell..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a Potential 228% Upside in the Healthcare Sector

Aura Biosciences, Inc. (NASDAQ: AURA), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating solid tumors. Headquartered in Boston, Massachusetts,..

Aurora Cannabis Inc. (ACB) Stock Analysis: Exploring a 75% Upside Potential

Aurora Cannabis Inc. (NASDAQ: ACB), a prominent player in the global cannabis industry, is generating significant buzz among investors with its potential upside of 75.33%. As a Canadian healthcare sector..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 36% Upside Potential in the Medical Devices Sector

For investors seeking opportunities in the burgeoning healthcare sector, Cytek Biosciences, Inc. (NASDAQ: CTKB) presents a compelling case. With a market capitalization of approximately $563.88 million, this U.S.-based medical devices..

Porch Group, Inc. (PRCH) Stock Analysis: Strong Buy Ratings and Nearly 100% Upside Potential

Porch Group, Inc. (NASDAQ: PRCH), a burgeoning player in the Financial Services sector, specifically within the Insurance – Property & Casualty industry, is catching the attention of investors with its..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Biotech Innovator with 138.51% Upside Potential

Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. Headquartered in Boston, Massachusetts, Compass is pioneering the development of innovative antibody-based therapeutics aimed..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating a Volatile 52-Week Range in the Healthcare Sector

Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT), a niche player in the healthcare sector, is engaged in the research, development, manufacturing, and sale of veterinary vaccines for livestock in China. The..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a 115% Potential Upside in the Biotech Sector

In the ever-evolving landscape of biotechnology, Tvardi Therapeutics, Inc. (NASDAQ: TVRD) emerges as a promising player focusing on groundbreaking therapies for fibrosis-driven diseases. Based in Sugar Land, Texas, Tvardi Therapeutics..

Neuronetics, Inc. (STIM) Stock Analysis: Is the 388% Potential Upside Enough to Attract Investors?

Neuronetics, Inc. (NASDAQ: STIM) is a healthcare company that has been capturing attention with its pioneering approach in medical devices, specifically through its NeuroStar Advanced Therapy System. This innovative technology..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Potential 209% Upside

In the ever-evolving world of biotechnology, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands out as a company with intriguing prospects, particularly for investors with a keen eye on long-term growth..

Viemed Healthcare, Inc. (VMD): Investor Outlook Reveals 43% Potential Upside in Respiratory Care Sector

Viemed Healthcare, Inc. (NASDAQ: VMD), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its robust revenue growth and significant potential..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 197% Potential Upside in the Healthcare Sector

Outset Medical, Inc. (NASDAQ: OM) stands at the intersection of innovation and opportunity in the healthcare sector, particularly within the medical devices industry. As a company dedicated to advancing hemodialysis..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a Potential 127% Upside

Investors looking into the biotechnology sector may find Fulcrum Therapeutics, Inc. (NASDAQ: FULC) an intriguing prospect, given its substantial potential upside of 127.54% based on current analyst price targets. With..

National Research Corporation (NRC) Investor Outlook: Evaluating High Dividend Yield Amidst Revenue Decline

National Research Corporation (NRC), a U.S.-based leader in health information services, offers investors a compelling mix of high dividend yield and challenges in revenue growth. With a market capitalization of..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a 118% Potential Upside

Investors with an eye on the biotechnology sector may find Benitec Biopharma Inc. (BNTC) an intriguing prospect, especially given its substantial potential upside of 118.45%. At its current price of..

Quantum-Si Incorporated (QSI): Investor Outlook on a Medical Device Innovator with 176% Potential Upside

Quantum-Si Incorporated (NASDAQ: QSI) presents a compelling case for investors seeking opportunities in the burgeoning field of medical devices, particularly in the innovative realm of Next Generation Protein Sequencing (NGPS)...

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Biotech Path with a Market Cap of $4.68 Billion

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotech sector with a market capitalization of $4.68 billion, catching the attention of investors eager to explore the potential of precision..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unveiling a 72.8% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) has emerged as a promising player in the biotechnology sector, captivating investors with its robust pipeline and strategic partnerships. With a market capitalization of $537.82..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 168% Potential Upside in the Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its intriguing position in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds